UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 293

Sortiert nach

Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection

The International journal of drug policy, 2023-01, Vol.111, p.101669-101669, Article 101669

2023

Link zum Volltext

Verfügbarkeit prüfen

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study

PloS one, 2018-08, Vol.13 (8), p.e0201120-e0201120

2018

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

Nature, 2005-08, Vol.436 (7053), p.967-972

2005

Link zum Volltext

Verfügbarkeit prüfen

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues

Current drug targets, 2017-01, Vol.18 (7), p.851

Feld, Jordan J

2017

Link zum Volltext

Verfügbarkeit prüfen

The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver

Canadian Medical Association journal (CMAJ), 2018-06, Vol.190 (22), p.E677

2018

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

The Journal of clinical investigation, 2023-01, Vol.133 (1), p.1-16

2023

Link zum Volltext

Verfügbarkeit prüfen

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

Nature communications, 2022-11, Vol.13 (1), p.6992-6992, Article 6992

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

PloS one, 2021-06, Vol.16 (6), p.e0253070

2021

Link zum Volltext

Verfügbarkeit prüfen

Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion

Nature communications, 2019-01, Vol.10 (1), p.481-481, Article 481

2019

Link zum Volltext

Verfügbarkeit prüfen

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

Proceedings of the National Academy of Sciences - PNAS, 2023-06, Vol.120 (24), p.e2220294120-e2220294120

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B and C in Pregnancy and Children: A Canadian Perspective

Viruses, 2022-12, Vol.15 (1), p.91

2022

Link zum Volltext

Verfügbarkeit prüfen

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening

PloS one, 2015-04, Vol.10 (4), p.e0120749-e0120749

2015

Link zum Volltext

Verfügbarkeit prüfen

What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?

The Journal of infectious diseases, 2024-05, Vol.229 (Supplement_3), p.S316-S321

Feld, Jordan J

2024

Link zum Volltext

Verfügbarkeit prüfen

Population-based estimate of hepatitis C virus prevalence in Ontario, Canada

PloS one, 2018-01, Vol.13 (1), p.e0191184-e0191184

2018

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness Analysis

Journal of clinical oncology, 2012-09, Vol.30 (26), p.3167-3173

2012

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3199-3202

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay

Viruses, 2021-05, Vol.13 (6), p.962

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study

Clinical infectious diseases, 2016-09, Vol.63 (6), p.776-783

2016

Link zum Volltext

Verfügbarkeit prüfen

Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression

Journal of virology, 2016-06, Vol.90 (12), p.5549-5560

2016

Link zum Volltext

Verfügbarkeit prüfen

HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection

Viruses, 2022-08, Vol.14 (8), p.1800

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009

PloS one, 2012-07, Vol.7 (7), p.e40917-e40917

2012

Link zum Volltext

Verfügbarkeit prüfen

Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling

Frontiers in immunology, 2021-10, Vol.12, p.748423-748423

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

BMC public health, 2020-09, Vol.20 (1), p.1345-1345, Article 1345

2020

Link zum Volltext

Verfügbarkeit prüfen

Absolute Ligand Discrimination by Dimeric Signaling Receptors

Biophysical journal, 2016-09, Vol.111 (5), p.917-920

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, Correlates, and Viral Dynamics of Hepatitis Delta among Injection Drug Users

The Journal of infectious diseases, 2010-09, Vol.202 (6), p.845-852

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 293

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

ThemaGastroenterology & Hepatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(265)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(116)
Humans
(105)
Hepatitis C
(55)
Hepatitis
(48)
Infectious Diseases
(48)
Antiviral Agents - Therapeutic Use
(47)
Female
(47)
Male
(45)
Immunology
(36)
Middle Aged
(35)
Adult
(32)
Hepatitis C, Chronic - Drug Therapy
(32)
Infections
(31)
Hepatitis C Virus
(26)
Hepacivirus - Genetics
(25)
Microbiology
(25)
Interferon
(24)
Patients
(23)
Aged
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gastroenterology
(23)
Journal Of Hepatology
(22)
Clinical Infectious Diseases
(20)
Hepatology
(12)
Journal Of Clinical Oncology
(12)
Clinical Liver Disease
(11)
The New England Journal Of Medicine
(10)
Plos One
(8)
The International Journal Of Drug Policy
(8)
Cmaj Open
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues

The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

Hepatitis B and C in Pregnancy and Children: A Canadian Perspective

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening

What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?

Population-based estimate of hepatitis C virus prevalence in Ontario, Canada

Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness Analysis

American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases

Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay

Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study

Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression

HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection

Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009

Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

Absolute Ligand Discrimination by Dimeric Signaling Receptors

Prevalence, Correlates, and Viral Dynamics of Hepatitis Delta among Injection Drug Users

Aktive Filter

Suchergebnisse filtern